Luminex said that it expects to launch the platform, to be called NeoPlex4, in 2011 and "once it receives regulatory clearance, [it] will be a fully automated, walk-away testing platform for multiplexed newborn screening."
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.